Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Awaiting development
Guidance and quality standards
Awaiting development
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Area of interest
Area of interest
COVID-19 (1)
Type
Type
Guidance (243)
Quality standard (30)
Guidance programme
Guidance programme
Highly specialised technologies guidance (7)
Interventional procedures guidance (20)
Technology appraisal guidance (216)
Apply filters
Showing 1 to 10 of 273
Guidance and quality standards awaiting development
Title
Type
Abatacept for preventing moderate to severe acute graft-versus-host disease after haematopoietic stem cell transplant in people 6 years and over TS ID 10679
Technology appraisal guidance
Abatacept for treating active idiopathic inflammatory myopathies TS ID 10095
Technology appraisal guidance
Abdominal aortic aneurysm
Quality standard
Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]
Technology appraisal guidance
Acne
Quality standard
Adrenal dysfunction
Quality standard
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Quality standard
Advocacy services for adults with health and social care needs
Quality standard
Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion-positive advanced non-small-cell lung cancer [ID5110]
Technology appraisal guidance
Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium
Interventional procedures guidance
Current page
1
2
3
…
28
Page
1
of
28
Next page
Results per page
10
25
50
All